title: [Uterine Sarcomas - a review].
abstract: Uterine sarcomas are a heterogeneous group, which constitutes about 8% of malignant uterine tumors. This heterogeneousness and rare occurrence were the main cause of non-uniform therapeutical management. In previously published papers, there were mainly retrospective assessments of the experience of individual centres. The basis of relevant conclusions of the studies, beside their prospectiveness, is the use of unified classification criteria. Currently, a completely new classification of uterine sarcomas is being used, which consists of leiomyosarcoma, endometrial stromal sarcomas and adenosarcomas. For classification of carcinosarcomas, there are valid new criteria of endometrial cancer classification. The basic therapeutic approach of leiomyosarcoma and endometrial stromal sarcomas is a surgical intervention. The gold standard is hysterectomy and salpingooophorectomy. Justifiability of lymphadenectomy is being discussed. For carcinosarcomas, the same recommendations as for the surgical treatment of prognostically unfavourable endometrial carcinoma are valid - hysterectomy, salpingooophorectomy, pelvic and paraaortal lymph node dissection and omentectomy. It is necessary to implement the new classification into clinical practice, to publish and evaluate existing papers, which take into account their basic thesis. Only then it will be possible to create unified therapies. They should be aimed to improve patients survival.
authors.affiliation: Klinika gynekologickej onkologie, OUSA a SZU Bratislava, Slovenska Republika. mklacko@ousa.sk
authors.forename: M
authors.initials: M
authors.lastname: Klačko
authors.forename: P
authors.initials: P
authors.lastname: Babala
authors.forename: P
authors.initials: P
authors.lastname: Mikloš
authors.forename: P
authors.initials: P
authors.lastname: Zuzák
authors.forename: M
authors.initials: M
authors.lastname: Chorváth
authors.forename: M
authors.initials: M
authors.lastname: Ondrušová
authors.forename: D
authors.initials: D
authors.lastname: Ondruš
mesh_terms: D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D012509:Sarcoma / Q000145:classification / Q000473:pathology / Q000628:therapy; D014594:Uterine Neoplasms / Q000145:classification / Q000473:pathology / Q000628:therapy